<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"alternative medicine":1,
"breast cancer":6,
"cohort study":1,
"lifestyle":1,
"prognosis":7,
"quality of life":1,
"Neck dissection":1,
"Neoplasm invasiveness":1,
"Reconstructive surgical procedures":1,
"Thyroid neoplasms":3,
"Thyroidectomy":3,
"Trachea":1,
"EMT":1,
"Src/FAK":1,
"TGFβ":1,
"V600EBRAF":1,
"thyroid cancer":15,
"drug resistance":1,
"molecular targeted therapy":1,
"mutation":1,
"thyroid neoplasm/drug therapy":1,
"chemoradiation":1,
"esophageal cancer":1,
"esophagectomy":1,
"gastrectomy":1,
"Biochemical incomplete response":1,
"Follow-up":1,
"Indeterminate response":1,
"Papillary thyroid cancer":7,
"Recurrences":1,
"Thyroglobulin":2,
"Adenocarcinoma":1,
"immunohistochemistry":3,
"lung carcinoma":1,
"metastasis":8,
"osteoclast-like giant cells":1,
"carcinoid":1,
"parotid":1,
"salivary gland":2,
"submandibular":1,
"thyroid":10,
"Gasless unilateral axillary approach":1,
"Oncologic outcomes":1,
"Papillary thyroid carcinoma":10,
"Recurrence":4,
"Robotic thyroidectomy":1,
"Fine-needle aspiration biopsy":2,
"lymph node thyroglobulin":1,
"thyroglobulin antibody":2,
"27 kd HEAT-SHOCK PROTEIN":1,
"ANTIOXIDANTS":1,
"OXIDANTS":1,
"THYROID TUMORS":1,
"Children":1,
"Congenital hypothyroidism":1,
"Cáncer de tiroides":2,
"Hipotiroidismo congénito":1,
"Ionising radiation":1,
"Niños":1,
"Radiación ionizante":1,
"Differentiated thyroid carcinoma":4,
"clinical decision making":1,
"clinical practice guidelines":1,
"computer-based support systems":1,
"thyroid nodules":4,
"aberrant subclavian":1,
"cervical origin":1,
"high subclavian":1,
"subclavian artery":1,
"subclavian embryology":1,
"Anaplastic thyroid carcinoma":1,
"Carcinoma anaplásico da tireoide":1,
"Leiomiossarcoma":1,
"Leiomyosarcoma":1,
"Sarcomas":1,
"Tiroide":1,
"endolaryngeal stent":1,
"hemicricoidectomy":1,
"larynx":1,
"partial laryngectomy":1,
"sarcoma":1,
"99mTc":1,
"99mTc-HMPAO":1,
"99mTc-MIBI":1,
"Clonogenic survival":1,
"radiotoxicity":1,
"γH2AX":1,
"Central compartment":1,
"Diagnostic imaging":1,
"Hypopharyngeal neoplasm":1,
"Laryngeal neoplasm":1,
"Lymphatic metastasis":1,
"Post-surgical":1,
"Stimulated thyroglobulin":1,
"Unstimulated highly sensitive thyroglobulin":1,
"Core-needle biopsy":1,
"Fine-needle aspiration":2,
"Thyroid nodule":6,
"Ultrasound":4,
"ACS NSQIP":1,
"base of tongue":1,
"oropharyngeal cancer":1,
"tonsil":1,
"transoral laser microsurgery (TLM)":1,
"transoral robotic surgery (TORS)":1,
"Differentially expressed gene":1,
"Disease-associated network":1,
"Pathway":1,
"Cartilage invasion":1,
"Hypopharyngeal":1,
"Laryngeal":1,
"Negative predictive value":1,
"Positive predictive value":1,
"Sensitivity":1,
"Specificity":1,
"Squamous cell carcinoma":1,
"Bethesda V":1,
"fine-needle aspiration (FNA)":1,
"frozen section":1,
"suspected malignancy":1,
"autopsy":1,
"cytology":4,
"minimally invasive autopsy":1,
"virtopsy":1,
"Indeterminate cytology":2,
"Predictive marker":1,
"differentiated thyroid cancer":2,
"radioiodine (131I) treatment":1,
"salivary gland damage":1,
"hormone replacement therapy":1,
"iodine administration route":1,
"microSPECT/CT":1,
"radioiodine therapy":1,
"recombinant human TSH":1,
"composite free flap":1,
"cricoid reconstruction":1,
"laryngotracheal reconstruction":1,
"prefabricated flap":1,
"recurrent papillary thyroid carcinoma":1,
"BRAF":3,
"TERT":1,
"radioactive iodine":2,
"tyrosine kinase inhibitors":2,
"Adolescent and young adult":1,
"Cancer survivor":1,
"Correlates":1,
"Fear of recurrence":1,
"Prevalence":1,
"case report":1,
"diagnostic pitfall":1,
"intrathyroidal parathyroid adenoma":1,
"PD1":1,
"PDL1":1,
"PDL2":1,
"lymphoma":1,
"melanoma":1,
"non-small cell lung cancer":1,
"pembrolizumab":1,
"solid tumors":1,
"laser":1,
"nodule":1,
"thermal ablation":1,
"MEN 2A":1,
"N0":1,
"microscopic MTC":1,
"parathyroidectomy":1,
"fine-needle aspiration biopsy (FNAB)":1,
"pediatric":1,
"Cáncer tiroideo incidental":1,
"Incidental thyroid cancer":1,
"Pronóstico":1,
"ablation":1,
"microcarcinoma":1,
"radiofrequency":1,
"Cancer: endocrine":1,
"medullary thyroid cancer":2,
"ras":1,
"ret":3,
"Classifier":1,
"Fine needle aspiration cytology":1,
"Follicular thyroid adenoma":1,
"Follicular thyroid cancer":1,
"High-throughput sequencing":1,
"miRNA":2,
"carcinomas":1,
"fatal":1,
"follicular":2,
"poorly differentiated":2,
"tall cell":1,
"color Doppler ultrasound":1,
"lymph node":3,
"neck":1,
"nodal metastasis":1,
"ultrasonography":3,
"major salivary glands":1,
"radioactive iodine ablation":1,
"ultrasonography, xerostomia":1,
"Growth":2,
"TNKS2":1,
"microRNA":1,
"Bioinformatics":1,
"DNAPTP3":1,
"Ductal carcinoma in situ (DCIS)":1,
"Invasive breast cancer":1,
"Incidence":2,
"Triggers":1,
"Afirma":1,
"fine needle aspiration":1,
"follicular lesion of undetermined significance":1,
"gene expression classifier":2,
"Acoustic structure quantification":1,
"Sialadenitis":2,
"Cancer":6,
"Frailty":1,
"Frailty index":1,
"Spinal metastatic tumor":1,
"Spine surgery":2,
"outcome":2,
"radioactive iodine therapy":2,
"timing of radioactive iodine administration":1,
"FNA":1,
"diagnostic":1,
"epidemiology":2,
"real-world study":1,
"survival":1,
"treatment":1,
"cold pressure test":1,
"coronary flow reserve":1,
"endothelial cells":1,
"recombinant human thyroid stimulating hormone":1,
"Pax 8":1,
"dog":1,
"napsin A":1,
"Ectopic":1,
"Endoscope":1,
"Pituitary adenoma":1,
"Suprasellar":1,
"Thyrotropin":1,
"Enhancing solid component":1,
"Magnetic resonance imaging (MRI)":1,
"Mature teratoma":1,
"Ovary":1,
"Pathology":1,
"Computed tomography":1,
"Incidental":1,
"review":1,
"systematic":1,
"environment":1,
"molecular genetics":1,
"thyroid carcinoma":2,
"Lipid vesicles":1,
"Lipid-drug interaction":1,
"Membrane structure":1,
"Order parameter":1,
"Regorafenib":1,
"Sorafenib":2,
"lymph nodes":1,
"humans":1,
"medullary thyroid carcinoma":4,
"multifocality":1,
"surgery":1,
"thyroid neoplasm":1,
"anaplastic":1,
"medullary":1,
"oncology":2,
"papillary":1,
"patient-reported outcomes":1,
"analytical verification":1,
"molecular diagnostic":1,
"CDKN2C":1,
"Rb pathway":1,
"haploinsufficiency":1,
"nc886":1,
"oncogene":2,
"protein kinase R":1,
"Aetiology":1,
"Drugs":1,
"Genes":1,
"Molecular biology":1,
"Obesity":1,
"Korea":1,
"overdiagnosis":1,
"screening":1,
"TSH":1,
"nodules":1,
"prediction":1,
"suppression":1,
"contralateral central neck compartment":1,
"lymph node metastasis":2,
"nomogram":1,
"Osteosarcoma":1,
"PKM2":2,
"AEs":1,
"CEA":1,
"DTC":1,
"EGFR":1,
"MTC":1,
"VEGFR":1,
"calcitonin":2,
"pediatric MTC":1,
"vandetanib":2,
"HMGA2":1,
"Invasion":1,
"MIR-185":1,
"RKIP":1,
"Cabozantinib":1,
"RET mutations":1,
"open-label trials":1,
"randomized trials":1,
"sunitinib":1,
"tyrosine-kinase inhibitors":1,
"CA 19 9":1,
"DUPAN-2":1,
"Tumor marker":1,
"Sheep":1,
"thymic cyst":1,
"thymoma":1,
"Ion Torrent":1,
"limited samples":1,
"molecular diagnosis":1,
"next-generation sequencing":2,
"postsequencing metrics":1,
"preanalytical factors":1,
"thyroid fine-needle aspiration":1,
"HER4/ErbB-4":1,
"marker":1,
"meta-analysis":1,
"electromagnetic therapy":1,
"pulsed electromagnetic fields":1,
"tumor-specific frequencies":1,
"differential diagnosis":1,
"paired box gene 8 (PAX8)":1,
"pulmonary neuroendocrine carcinoma (PNEC)":1,
"thymic neuroendocrine carcinoma (TNEC)":1,
"thyroid transcription factor-1 (TTF-1)":1,
"Gynecologic Neoplasms":1,
"Thailand":1,
"Microwave ablation":1,
"Pain scale":1,
"Ultrasound-guidance":1,
"Volume reduction":1,
"Histoculture drug response assay":1,
"clinicopathological factors":1,
"head and neck ultrasound":1,
"shear wave elastography":1,
"papillary thyroid microcarcinoma":1,
"sonography":1,
"superficial structures":1,
"Matrix metalloproteinase 9":1,
"Prognostic biomarkers":1,
"Vascular endothelial growth factor C":1,
"Multiple endocrine neoplasia":1,
"phenoxybenzamine":1,
"pheochromocytoma":1,
"pregnancy":1,
"Breast sentinel lymph node biopsy":1,
"Fluorescein sodium":1,
"Isosulfan blue":1,
"Consensus reading":1,
"Iodine-negative":1,
"Lymph node metastases":1,
"MRI":1,
"Negative ultrasound":1,
"Nodal metastases":1,
"PET/CT":1,
"Recurrent thyroid cancer":1,
"Recurrent thyroid carcinoma":1,
"autophagy":1,
"defective ciliogenesis":1,
"primary cilia":1,
"thyroid hürthle cell":1,
"Cancer thyroïdien métastatique":1,
"Lenvatinib":1,
"Radioiodine refractory Thyroid cancer":1,
"Réfractaire à l’iode":1,
"Sorafénib":1,
"Thyroïde":1,
"I-131":2,
"radioiodine":1,
"salivary gland dysfunction":1,
"thyroid treatment":1,
"EWSR1-NR4A3":1,
"Extraskeletal myxoid chondrosarcoma":1,
"Fluorescence in situ hybridization":1,
"Carcinoembryonic antigen":1,
"RET proto-oncogene mutation":1,
"Sporadic medullary thyroid carcinoma":1,
"Cavernous sinus":1,
"Complications":1,
"Endoscopy":1,
"Pituitary neoplasms":1,
"Reliability":1,
"Transsphenoidal surgery":1,
"Hurthle cell lesion":1,
"follicular cell carcinoma":1,
"minimally invasive HCC":1,
"cancer genomics":1,
"gene expression":1,
"gene fusion":1,
"somatic structural variation":1,
"BRAF mutation":1,
"A-bomb":1,
"GAM":1,
"Low dose radiation":1,
"Uterus":1,
"Women":1,
"depression":1,
"heart disease":1,
"hot flashes":1,
"isoflavones":1,
"nutrient content":1,
"renal function":1,
"safety":1,
"soy":1,
"soyfoods":1,
"Epigenetics":1,
"chromatin":1,
"germ cell neoplasms":1,
"seminoma":1,
"NRP-2":1,
"VEGF-C":1,
"lymphangiogenesis":1,
"tumor metastasis":1,
"clear cell":1,
"parathyroid":1,
"renal carcinoma":1,
"hepatocellular carcinoma":1,
"overall survival":1,
"propensity score matching":1,
"recurrence-free survival rate":1,
"thymosin α1":1,
"E-cadherin":1,
"Snail":1,
"epithelial-mesenchymal transition":2,
"MicroRNA-101":1,
"tumorigenesis":1,
"ubiquitin-specific protease 22":1,
"mammalian target of rapamycin":1,
"metformin":1,
"ARAP3":1,
"next-generation sequence":1,
"Prolactinoma":1,
"prolactin":1,
"thyroid volume":1,
"Knitted TiNi-based mesh endograft":1,
"Prefabrication":1,
"Sparing surgery":1,
"Thyroid papillary carcinoma":2,
"Tracheal reconstruction":1,
"cervical spine":1,
"intradural metastasis":1,
"intradural tumor":1,
"nerve root":1,
"nerve root metastasis":1,
"spinal metastasis":1,
"thyroid follicular carcinoma":1,
"Breast":1,
"Fat necrosis":1,
"Carcinoma de Células Renais":1,
"Metástase Neoplásica":1,
"Neoplasias da Tiróide/secundária":1,
"androgen receptor":1,
"interleukin-6":1,
"silencing mediator for retinoid and thyroid hormone receptors":1,
"steroid receptor coactivator-1":1,
"cell cycle":1,
"cell proliferation":1,
"miRNA-203":1,
"NIFT-P":1,
"follicular variant":1,
"non-invasive":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年11月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
